Tata Chemicals Limited has informed the Exchange about Transcript
TATACHEM · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Tata Chemicals reported Q4 FY26 consolidated revenue of INR 3,438 crores (down 2% YoY) with EBITDA at INR 274 crores versus INR 327 crores in Q4 last year, impacted by subdued soda ash prices across all geographies. The company took an exceptional charge of INR 1,837 crores for goodwill impairment in US operations plus INR 159 crores deferred tax write-off. Standalone revenue was INR 1,254 crores (up 3%) but PAT from continuing operations fell 51% to INR 48 crores. Management highlighted that Middle East geopolitical tensions have disrupted supply chains, increasing energy, raw material and shipping costs, with Kenya being most vulnerable due to HFO dependency on Middle East imports. Cost increases have been passed on to customers across regions. Non-soda ash revenue grew 14% to INR 6,946 crores in FY26, aligned with strategic shift. FY27 capex is planned at INR 1,300 crores, with net debt expected to remain around INR 6,000 crores.
The impairment charge and weaker profitability reflect continued soda ash cycle weakness, but management's focus on cost pass-through and shift to non-soda ash businesses provides some cushion. The INR 1,300 crore capex guidance and flat debt outlook suggest limited near-term deleveraging.